Emmace

We are a world leading testing and advising CRO (Contract Research Organisation) in product development of orally inhaled and nasal drug products. Our goal is to contribute to better health and increase quality of life all over the world.

Our world leading inhalation advisors are here for your support.

Excellence in testing of and advising on inhalers, nebulizers, nasal and medical respiratory devices.

We are here to support you with inhaler, nebulizer and medical device testing as well as advising on how to proceed with your product development.

Our extensive experience covers testing of

DPIs (Dry Powder Inhalers)
Soft mist devices
pMDIs (pressurised Metered Dose Inhalers)
Nebulizers
Nasal devices
Medical devices in respiratory care
Advanced analytical services

We also offer advising by world leading experts regarding

Development of dry powder formulations for inhalation
Modelling of lung dose and prediction of expose
Biocompatibility of medical devices

During more than 10 years, we have supported over 100 clients. Many of them are repeat customers. Contact us to learn what we can do for you.

What We Offer

Analytical services

Advising

Products

Collaborations and Partners

LU_LTH_logotype — Emmace collaborates with Department of Food Technology, Engineering and Nutrition, LTH, Faculty of Engineering.

Emmace has together with Prof. Jurgen Bulitta and Prof. Guenther Hochhaus research groups at University of Florida, collaborated since 2015 in different FDA sponsored grants and research projects. The work has resulted in several joint publications.

Emmace has a strong global network and is particularly proud to be a member of the Medicon Valley Inhalation Consortium (MVIC AB), a Swedish cluster consisting of over 20 companies working with inhalation product development.

Per Backman_Consulting_logotype — Dr. Bäckman assists clients with the discovery and development of inhaled medicines. This includes for example: establishing in vitro-in vivo correlations in support of specifications and product design targets and IVIVC model-based batch selection for BE studies.

Epag_logotype — Emmace is a member of the impactor sub-group of the European Pharmaceutical Aerosol Group (EPAG)

Per Bäckman, Senior Advisor, is member of Development of a Biopharmaceutics Classification System (BCS) for Pulmonary Drugs, a working group under Biopharmaceutics Technical Committee (BTC).

Magle ChemoSwed has world-class expertise in solid-state analysis and interacts very closely with Emmace on several projects. Read more about Magle ChemoSwed here and more about their competence in Inhalation.

Development work almost always requires specialized lab hardware. Emmace collaborates with AB FIA and Prototypverkstaden (FIA Labs) to devise, build, and test custom equipment and concepts.

News from Emmace

View News